Production (Stage)
Cognition Therapeutics, Inc.
CGTX
$0.3225
$0.02428.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 16.43M | 25.01M | 22.01M | 28.53M | 34.67M |
| Total Receivables | 4.78M | 2.69M | 3.37M | 3.10M | 861.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.66M | 1.86M | 1.45M | 1.92M | 2.44M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 22.87M | 29.56M | 26.83M | 33.55M | 37.97M |
|
|
|||||
| Total Current Assets | 22.87M | 29.56M | 26.83M | 33.55M | 37.97M |
| Net Property, Plant & Equipment | 634.00K | 679.00K | 749.00K | 819.00K | 883.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 23.50M | 30.23M | 27.58M | 34.37M | 38.85M |
|
|
|||||
| Total Accounts Payable | 1.82M | 1.98M | 1.90M | 3.03M | 2.64M |
| Total Accrued Expenses | 7.71M | 7.62M | 9.51M | 6.06M | 4.73M |
| Short-term Debt | 161.00K | 279.00K | -- | 185.00K | 366.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 194.00K | 193.00K | 188.00K | 184.00K | 180.00K |
| Total Finance Division Other Current Liabilities | 1.07M | 1.07M | 1.12M | 1.45M | 3.53M |
| Total Other Current Liabilities | 1.07M | 1.07M | 1.12M | 1.45M | 3.53M |
| Total Current Liabilities | 10.95M | 11.14M | 12.71M | 10.92M | 9.50M |
|
|
|||||
| Total Current Liabilities | 10.95M | 11.14M | 12.71M | 10.92M | 9.50M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 161.00K | 279.00K | -- | 185.00K | 366.00K |
| Capital Leases | 280.00K | 342.00K | 392.00K | 440.00K | 488.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 11.23M | 11.48M | 13.10M | 11.36M | 9.99M |
|
|
|||||
| Common Stock & APIC | 195.91M | 193.91M | 181.80M | 180.39M | 179.20M |
| Retained Earnings | -183.64M | -175.16M | -167.32M | -157.38M | -150.34M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 12.27M | 18.75M | 14.48M | 23.01M | 28.86M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 12.27M | 18.75M | 14.48M | 23.01M | 28.86M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 12.27M | 18.75M | 14.48M | 23.01M | 28.86M |
|
|
|||||